Phase-wise evaluation and optimization of non-pharmaceutical interventions to contain the COVID-19 pandemic in the U.S
- PMID: 37601210
- PMCID: PMC10434774
- DOI: 10.3389/fpubh.2023.1198973
Phase-wise evaluation and optimization of non-pharmaceutical interventions to contain the COVID-19 pandemic in the U.S
Abstract
Given that the effectiveness of COVID-19 vaccines and other therapies is greatly limited by the continuously emerging variants, non-pharmaceutical interventions have been adopted as primary control strategies in the global fight against the COVID-19 pandemic. However, implementing strict interventions over extended periods of time is inevitably hurting the economy. Many countries are faced with the dilemma of how to take appropriate policy actions for socio-economic recovery while curbing the further spread of COVID-19. With an aim to solve this multi-objective decision-making problem, we investigate the underlying temporal dynamics and associations between policies, mobility patterns, and virus transmission through vector autoregressive models and the Toda-Yamamoto Granger causality test. Our findings reveal the presence of temporal lagged effects and Granger causality relationships among various transmission and human mobility variables. We further assess the effectiveness of existing COVID-19 control measures and explore potential optimal strategies that strike a balance between public health and socio-economic recovery for individual states in the U.S. by employing the Pareto optimality and genetic algorithms. The results highlight the joint power of the state of emergency declaration, wearing face masks, and the closure of bars, and emphasize the necessity of pursuing tailor-made strategies for different states and phases of epidemiological transmission. Our framework enables policymakers to create more refined designs of COVID-19 strategies and can be extended to other countries regarding best practices in pandemic response.
Keywords: COVID-19 pandemic; human mobility; multi-objective optimization; multivariate time series analysis; non-pharmaceutical interventions; public health policymaking.
Copyright © 2023 Zhou, Zhang, Santi and Ratti.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- World Health Organization . Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV), Vol. 30. Geneva: World Health Organization; (2020).
-
- World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. (2022). Available online at: https://covid19.who.int (accessed July 06, 2022).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
